Dilation Capital Management’s Linde LIN Stock Holding History

Dilation Capital Management’s Portfolio LIN Stock Details LIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.27M	Buy	+12,645	New	+$5.97M	3.15%	17

Other funds holding LIN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dilation Capital Management's LIN Position: Q1 2026 in Review

Dilation Capital Management opened a new position in Linde (LIN) in Q1 2026: 12,645 shares worth $6.27M. The stake represents 3.15% of the portfolio and ranks #17 among its holdings.

2,268 funds tracked by Wall St. Rank hold LIN as of Q1 2026.

Dilation Capital Management held 12,645 shares of Linde worth $6.27M as of Q1 2026.
Linde was a new Dilation Capital Management position in Q1 2026.
Linde made up 3.15% of Dilation Capital Management's portfolio in Q1 2026, its #17 holding.
2,268 funds tracked by Wall St. Rank held Linde as of Q1 2026.

Based on Dilation Capital Management's 13F filing for Q1 2026, filed 29 Apr 2026.